Net profit of Fredun Pharmaceuticals rose 8.38% to Rs 4.27 crore in the quarter ended September 2024 as against Rs 3.94 crore during the previous quarter ended September 2023. Sales rose 31.19% to Rs 106.89 crore in the quarter ended September 2024 as against Rs 81.48 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 106.89 | 81.48 | 31 |
| OPM % | 13.04 | 11.79 | - |
| PBDT | 8.63 | 6.71 | 29 |
| PBT | 7.57 | 5.77 | 31 |
| NP | 4.27 | 3.94 | 8 |